Pharmabiz

OGT expands MRD detection capabilities with new SureSeq Myeloid MRD Plus NGS Panel

OGT expands MRD detection capabilities with new SureSeq Myeloid MRD Plus NGS Panel: Oxford, UK Wednesday, November 12, 2025, 17:00 Hrs [IST] Oxford Gene Technology (OGT), a Sysmex ...
ascopubs.org

Detection of homologous recombination deficiency (HRD) in cell-free DNA (cfDNA) using an amplicon-based next-generation sequencing (NGS) assay.

Early detection of cancer using cell-free DNA (cfDNA) size analysis on a multiplexed amplicon-based next-generation sequencing (NGS) platform. Systemic levels of the soluble co-inhibitory immune ...
GEN

Light-Seq: Full-Transcriptome Sequencing of Hard-to-Access Cells

A new spatial transcriptomics technology—the DNA nanotechnology-driven method called “Light-Seq”—allows researchers to “geotag” the full repertoire of RNA sequences with unique DNA barcodes exclusive ...

Geneseeq Receives NMPA Approval for PanTRKare™ - China's First NGS-Based Pan-Solid Tumor Companion Diagnostic Kit for NTRK Gene Fusions

TORONTO, Nov. 10, 2025 /CNW/ - Geneseeq Technology Inc., a global precision oncology company, today announced its PanTRKare™NTRK1/NTRK2/NTRK3 Gene Fusion Detection Kit has received marketing authoriza ...
ascopubs.org

Next-Generation Sequencing of Advanced GI Tumors Reveals Individual Treatment Options

Clinical Relevance of an Amplicon-Based Liquid Biopsy for Detecting ALK and ROS1 Fusion and Resistance Mutations in Patients With Non–Small-Cell Lung Cancer Precision oncology connects highly complex ...